report cover

Liquid Biopsy Diagnostic Tool Market, Global Outlook and Forecast 2022-2028

  • 15 April 2022
  • Life Sciences
  • 102 Pages
  • Report code : 24WT-7000737

Liquid Biopsy Diagnostic Tool and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Liquid Biopsy Diagnostic Tool Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liquid Biopsy Diagnostic Tool Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liquid Biopsy Diagnostic Tool Overall Market Size
2.1 Global Liquid Biopsy Diagnostic Tool Market Size: 2021 VS 2028
2.2 Global Liquid Biopsy Diagnostic Tool Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liquid Biopsy Diagnostic Tool Players in Global Market
3.2 Top Global Liquid Biopsy Diagnostic Tool Companies Ranked by Revenue
3.3 Global Liquid Biopsy Diagnostic Tool Revenue by Companies
3.4 Top 3 and Top 5 Liquid Biopsy Diagnostic Tool Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liquid Biopsy Diagnostic Tool Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liquid Biopsy Diagnostic Tool Players in Global Market
3.6.1 List of Global Tier 1 Liquid Biopsy Diagnostic Tool Companies
3.6.2 List of Global Tier 2 and Tier 3 Liquid Biopsy Diagnostic Tool Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Liquid Biopsy Diagnostic Tool Market Size Markets, 2021 & 2028
4.1.2 Instrument
4.1.3 Reagent
4.1.4 Other
4.2 By Type - Global Liquid Biopsy Diagnostic Tool Revenue & Forecasts
4.2.1 By Type - Global Liquid Biopsy Diagnostic Tool Revenue, 2017-2022
4.2.2 By Type - Global Liquid Biopsy Diagnostic Tool Revenue, 2023-2028
4.2.3 By Type - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liquid Biopsy Diagnostic Tool Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Third-party Testing Agency
5.2 By Application - Global Liquid Biopsy Diagnostic Tool Revenue & Forecasts
5.2.1 By Application - Global Liquid Biopsy Diagnostic Tool Revenue, 2017-2022
5.2.2 By Application - Global Liquid Biopsy Diagnostic Tool Revenue, 2023-2028
5.2.3 By Application - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Liquid Biopsy Diagnostic Tool Market Size, 2021 & 2028
6.2 By Region - Global Liquid Biopsy Diagnostic Tool Revenue & Forecasts
6.2.1 By Region - Global Liquid Biopsy Diagnostic Tool Revenue, 2017-2022
6.2.2 By Region - Global Liquid Biopsy Diagnostic Tool Revenue, 2023-2028
6.2.3 By Region - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Liquid Biopsy Diagnostic Tool Revenue, 2017-2028
6.3.2 US Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.3.3 Canada Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.3.4 Mexico Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Liquid Biopsy Diagnostic Tool Revenue, 2017-2028
6.4.2 Germany Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4.3 France Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4.4 U.K. Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4.5 Italy Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4.6 Russia Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4.7 Nordic Countries Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.4.8 Benelux Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Liquid Biopsy Diagnostic Tool Revenue, 2017-2028
6.5.2 China Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.5.3 Japan Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.5.4 South Korea Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.5.5 Southeast Asia Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.5.6 India Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Liquid Biopsy Diagnostic Tool Revenue, 2017-2028
6.6.2 Brazil Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.6.3 Argentina Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liquid Biopsy Diagnostic Tool Revenue, 2017-2028
6.7.2 Turkey Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.7.3 Israel Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.7.4 Saudi Arabia Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
6.7.5 UAE Liquid Biopsy Diagnostic Tool Market Size, 2017-2028
7 Players Profiles
7.1 Biocept
7.1.1 Biocept Corporate Summary
7.1.2 Biocept Business Overview
7.1.3 Biocept Liquid Biopsy Diagnostic Tool Major Product Offerings
7.1.4 Biocept Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.1.5 Biocept Key News
7.2 Qiagen
7.2.1 Qiagen Corporate Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Liquid Biopsy Diagnostic Tool Major Product Offerings
7.2.4 Qiagen Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.2.5 Qiagen Key News
7.3 Roche Diagnostics
7.3.1 Roche Diagnostics Corporate Summary
7.3.2 Roche Diagnostics Business Overview
7.3.3 Roche Diagnostics Liquid Biopsy Diagnostic Tool Major Product Offerings
7.3.4 Roche Diagnostics Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.3.5 Roche Diagnostics Key News
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Corporate Summary
7.4.2 Bio-Rad Laboratories Business Overview
7.4.3 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Major Product Offerings
7.4.4 Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.4.5 Bio-Rad Laboratories Key News
7.5 Myriad Genetics
7.5.1 Myriad Genetics Corporate Summary
7.5.2 Myriad Genetics Business Overview
7.5.3 Myriad Genetics Liquid Biopsy Diagnostic Tool Major Product Offerings
7.5.4 Myriad Genetics Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.5.5 Myriad Genetics Key News
7.6 Menarini-Silicon Biosystems
7.6.1 Menarini-Silicon Biosystems Corporate Summary
7.6.2 Menarini-Silicon Biosystems Business Overview
7.6.3 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Major Product Offerings
7.6.4 Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.6.5 Menarini-Silicon Biosystems Key News
7.7 Trovagene
7.7.1 Trovagene Corporate Summary
7.7.2 Trovagene Business Overview
7.7.3 Trovagene Liquid Biopsy Diagnostic Tool Major Product Offerings
7.7.4 Trovagene Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.7.5 Trovagene Key News
7.8 Guardant Health
7.8.1 Guardant Health Corporate Summary
7.8.2 Guardant Health Business Overview
7.8.3 Guardant Health Liquid Biopsy Diagnostic Tool Major Product Offerings
7.8.4 Guardant Health Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.8.5 Guardant Health Key News
7.9 Mdxhealth
7.9.1 Mdxhealth Corporate Summary
7.9.2 Mdxhealth Business Overview
7.9.3 Mdxhealth Liquid Biopsy Diagnostic Tool Major Product Offerings
7.9.4 Mdxhealth Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.9.5 Mdxhealth Key News
7.10 Genomic Health
7.10.1 Genomic Health Corporate Summary
7.10.2 Genomic Health Business Overview
7.10.3 Genomic Health Liquid Biopsy Diagnostic Tool Major Product Offerings
7.10.4 Genomic Health Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.10.5 Genomic Health Key News
7.11 Raindance Technologies
7.11.1 Raindance Technologies Corporate Summary
7.11.2 Raindance Technologies Business Overview
7.11.3 Raindance Technologies Liquid Biopsy Diagnostic Tool Major Product Offerings
7.11.4 Raindance Technologies Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.11.5 Raindance Technologies Key News
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Corporate Summary
7.12.2 Thermo Fisher Scientific Business Overview
7.12.3 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Major Product Offerings
7.12.4 Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.12.5 Thermo Fisher Scientific Key News
7.13 Illumina
7.13.1 Illumina Corporate Summary
7.13.2 Illumina Business Overview
7.13.3 Illumina Liquid Biopsy Diagnostic Tool Major Product Offerings
7.13.4 Illumina Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.13.5 Illumina Key News
7.14 Amoy Diagnostics
7.14.1 Amoy Diagnostics Corporate Summary
7.14.2 Amoy Diagnostics Business Overview
7.14.3 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Major Product Offerings
7.14.4 Amoy Diagnostics Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.14.5 Amoy Diagnostics Key News
7.15 Johnson & Johnson
7.15.1 Johnson & Johnson Corporate Summary
7.15.2 Johnson & Johnson Business Overview
7.15.3 Johnson & Johnson Liquid Biopsy Diagnostic Tool Major Product Offerings
7.15.4 Johnson & Johnson Liquid Biopsy Diagnostic Tool Revenue in Global Market (2017-2022)
7.15.5 Johnson & Johnson Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Liquid Biopsy Diagnostic Tool Market Opportunities & Trends in Global Market
Table 2. Liquid Biopsy Diagnostic Tool Market Drivers in Global Market
Table 3. Liquid Biopsy Diagnostic Tool Market Restraints in Global Market
Table 4. Key Players of Liquid Biopsy Diagnostic Tool in Global Market
Table 5. Top Liquid Biopsy Diagnostic Tool Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liquid Biopsy Diagnostic Tool Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liquid Biopsy Diagnostic Tool Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liquid Biopsy Diagnostic Tool Product Type
Table 9. List of Global Tier 1 Liquid Biopsy Diagnostic Tool Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liquid Biopsy Diagnostic Tool Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liquid Biopsy Diagnostic Tool Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liquid Biopsy Diagnostic Tool Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liquid Biopsy Diagnostic Tool Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liquid Biopsy Diagnostic Tool Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2023-2028
Table 30. Biocept Corporate Summary
Table 31. Biocept Liquid Biopsy Diagnostic Tool Product Offerings
Table 32. Biocept Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 33. Qiagen Corporate Summary
Table 34. Qiagen Liquid Biopsy Diagnostic Tool Product Offerings
Table 35. Qiagen Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 36. Roche Diagnostics Corporate Summary
Table 37. Roche Diagnostics Liquid Biopsy Diagnostic Tool Product Offerings
Table 38. Roche Diagnostics Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Laboratories Corporate Summary
Table 40. Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Product Offerings
Table 41. Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 42. Myriad Genetics Corporate Summary
Table 43. Myriad Genetics Liquid Biopsy Diagnostic Tool Product Offerings
Table 44. Myriad Genetics Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 45. Menarini-Silicon Biosystems Corporate Summary
Table 46. Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Product Offerings
Table 47. Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 48. Trovagene Corporate Summary
Table 49. Trovagene Liquid Biopsy Diagnostic Tool Product Offerings
Table 50. Trovagene Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 51. Guardant Health Corporate Summary
Table 52. Guardant Health Liquid Biopsy Diagnostic Tool Product Offerings
Table 53. Guardant Health Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 54. Mdxhealth Corporate Summary
Table 55. Mdxhealth Liquid Biopsy Diagnostic Tool Product Offerings
Table 56. Mdxhealth Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 57. Genomic Health Corporate Summary
Table 58. Genomic Health Liquid Biopsy Diagnostic Tool Product Offerings
Table 59. Genomic Health Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 60. Raindance Technologies Corporate Summary
Table 61. Raindance Technologies Liquid Biopsy Diagnostic Tool Product Offerings
Table 62. Raindance Technologies Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 63. Thermo Fisher Scientific Corporate Summary
Table 64. Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Product Offerings
Table 65. Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 66. Illumina Corporate Summary
Table 67. Illumina Liquid Biopsy Diagnostic Tool Product Offerings
Table 68. Illumina Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 69. Amoy Diagnostics Corporate Summary
Table 70. Amoy Diagnostics Liquid Biopsy Diagnostic Tool Product Offerings
Table 71. Amoy Diagnostics Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
Table 72. Johnson & Johnson Corporate Summary
Table 73. Johnson & Johnson Liquid Biopsy Diagnostic Tool Product Offerings
Table 74. Johnson & Johnson Liquid Biopsy Diagnostic Tool Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Liquid Biopsy Diagnostic Tool Segment by Type in 2021
Figure 2. Liquid Biopsy Diagnostic Tool Segment by Application in 2021
Figure 3. Global Liquid Biopsy Diagnostic Tool Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liquid Biopsy Diagnostic Tool Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liquid Biopsy Diagnostic Tool Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liquid Biopsy Diagnostic Tool Revenue in 2021
Figure 8. By Type - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 12. US Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 16. Germany Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 17. France Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 24. China Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 28. India Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 30. Brazil Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liquid Biopsy Diagnostic Tool Revenue Market Share, 2017-2028
Figure 33. Turkey Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liquid Biopsy Diagnostic Tool Revenue, (US$, Mn), 2017-2028
Figure 37. Biocept Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qiagen Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche Diagnostics Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad Laboratories Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Myriad Genetics Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Menarini-Silicon Biosystems Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Trovagene Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Guardant Health Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mdxhealth Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genomic Health Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Raindance Technologies Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Thermo Fisher Scientific Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Illumina Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Amoy Diagnostics Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Johnson & Johnson Liquid Biopsy Diagnostic Tool Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Liquid Biopsy Diagnostic Tool and Forecast Market

Leave This Empty: